Publications by authors named "Philippe Bilodeau"

Claim this Profile
R
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.
Philippe A Bilodeau, Mattia Wruble Clark, Avanteeka Ganguly, Jenna Bernice Harowitz, Joao Vitor Mahler

Neurol Neuroimmunol Neuroinflamm· March 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A threshold in anti-EBNA-1 antibody titers distinguishes salivary EBV shedders from non-shedders.
João Vitor Mahler, Philippe A Bilodeau, Monique Anderson, Takahisa Mikami, Natasha Bobrowski-Khoury

J Infect Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychologic impact of MOGAD: A patient reported outcomes study.
Bruna Leles, Yihan Zhang, Philippe A Bilodeau, Anastasia Vishnevetsky, Takahisa Mikami

Mult Scler Relat Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of model for predicting risk of relapse in MOGAD.
Mulan Jiang, Philippe Antoine Bilodeau, Brian Healy, E Ann Yeh, Gavin Giovannoni

Mult Scler Relat Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential mechanisms of how B-cell depletion works in MOGAD.
Philippe A Bilodeau, Ann Yeh, Jeannette Lechner-Scott, Christopher H Hawkes, Gavin Giovannoni

Mult Scler Relat Disord· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 T cells restricted to DRB1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentation.
Natalia Drosu, Monique Anderson, Philippe A Bilodeau, Shuhei Nishiyama, Takahisa Mikami

Proc Natl Acad Sci U S A· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term MRI and clinical stability in an HIV-positive patient with multiple sclerosis on tenofovir: A case report.
Natalia Drosu, Kjetil Bjornevik, Philippe Bilodeau, Michael Levy

Mult Scler Relat Disord· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.
Philippe Antoine Bilodeau, Anastasia Vishnevetsky, Negar Molazadeh, Itay Lotan, Monique Anderson

Mult Scler· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, Gauruv Bose, Itay Lotan

J Neurol Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In the era of antiviral trials for MS, the answer lies in the details.
Natalia Drosu, Kjetil Bjornevik, Philippe A Bilodeau, Ann Yeh, Jeannette Lechner-Scott

Mult Scler Relat Disord· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders.
Shuhei Nishiyama, Jin Myong Seok, Amy E Wright, Itay Lotan, Takahisa Mikami, Philippe A Bilodeau

Sci Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Anti-Amyloid Immunotherapies on Stroke Care.
Philippe A Bilodeau, John R Dickson, Mariel G Kozberg

J Clin Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD).
Itay Lotan, Gabriela Romanow, Rebecca Salky, Negar Molazadeh, Anastasia Vishnevetsky, Philippe Antoine Bilodeau

Ann Clin Transl Neurol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple types of relapses in MOG antibody disease.
Michael Levy, Negar Molazadeh, Philippe Antoine Bilodeau, Anastasia Vishnevetsky, Itay Lotan

Mult Scler Relat Disord· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More Than a Little Unsteady.
Andrew W Kraft, Anand Vaidya, Philippe A Bilodeau, Denis Balaban, Steven E Arnold

N Engl J Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting.
Philippe A Bilodeau, Vinayak Kumar, Andrew E Rodriguez, Clarence T Li, Catalina Sanchez-Alvarez

Mult Scler· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partnered Educational Governance: Rethinking Student Agency in Undergraduate Medical Education.
Philippe Antoine Bilodeau, Xin Mei Liu, Beth-Ann Cummings

Acad Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Function-Related Molecular Profile of Adult Human A2B5-Positive Pre-Oligodendrocytes Versus Mature Oligodendrocytes.
Caroline Esmonde-White, Moein Yaqubi, Philippe A Bilodeau, Qiao Ling Cui, Florian Pernin

J Neuropathol Exp Neurol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation.
Philippe A Bilodeau, Erin S Coyne, Simon S Wing

Am J Physiol Cell Physiol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis